Skip to main content
    E

    Equillium Inc (EQ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.15
    -0.14 (-10.85%)

    Market Cap: $106.20M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Equillium Inc (EQ) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Equillium are Immunic (IMUX), ImmuCell (ICCC) and Eledon Pharmaceuticals (ELDN). By market cap, Equillium ranks 4th of the 13 companies on this page; Immuneering (IMRX) is the largest at $240.27M.

    Peer Comparison

    EQ's revenue growth of -52.3% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Equillium (EQ)$106.20MN/A29.3x0.0%N/A-52.3%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    ImmuCell Corporation (ICCC)$97.73M57.2x3.1x2.6%4.6%11.5%0.00%
    Eledon Pharmaceuticals Inc (ELDN)$178.63MN/AN/A0.0%N/A0.0%0.00%
    Cellectis SA (CLLS)$118.86MN/A1.8x0.0%-74.1%-85.4%0.00%
    Coherus BioSciences Inc (CHRS)$81.21MN/A1.5x-253.4%-144.8%23.4%0.00%
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Immuneering Corp (IMRX)$240.27MN/AN/A0.0%N/A-99.8%0.00%
    Seer Inc (SEER)$87.63MN/A5.8x0.0%N/A-3.4%0.00%
    Elicio Therapeutics Inc. (ELTX)$42.46MN/AN/A0.0%-96.6%0.0%0.00%
    Unicycive Therapeutics Inc (UNCY)$97.25MN/AN/A0.0%N/A0.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Peer median$97.49M57.2x3.1x0.0%-96.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Equillium, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    ImmuCell Corporation (ICCC)
    ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle...
    ICCC competitors
    Eledon Pharmaceuticals Inc (ELDN)
    Eledon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing drugs for patients living with autoimmune diseases...
    ELDN competitors
    Cellectis SA (CLLS)
    Cellectis SA, a clinical-stage biotechnology company, develops immuno-oncology products based on gene-edited T cells that express chimeric antigen receptors...
    CLLS competitors
    Coherus BioSciences Inc (CHRS)
    Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States.
    CHRS competitors
    OUTLOOK THERAPEUTICS INC (OTLK)
    Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic...
    OTLK competitors
    Immuneering Corp (IMRX)
    Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its...
    IMRX competitors
    Seer Inc (SEER)
    Seer, Inc., a life sciences company, is dedicated to developing and marketing products for researchers to unlock biological information.
    SEER competitors
    Elicio Therapeutics Inc. (ELTX)
    Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment.
    ELTX competitors
    Unicycive Therapeutics Inc (UNCY)
    Unicycive Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering therapies for kidney diseases...
    UNCY competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors

    Frequently Asked Questions About EQ

    Who are Equillium's main competitors?

    The companies most similar to Equillium include Immunic (IMUX), ImmuCell (ICCC), Eledon Pharmaceuticals (ELDN), Cellectis SA (CLLS) and Coherus BioSciences (CHRS), listed from the closest match.

    Who is Equillium's biggest competitor?

    Immuneering (IMRX) is the largest of the similar companies at $240.27M; Immunic (IMUX) is the closest match by business profile, size, sector and industry.

    How does EQ stock compare with its competitors?

    EQ's P/S is 29.3x against a peer median of 3.1x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Equillium's competitors pays a higher dividend?

    Equillium pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Equillium bigger than its competitors?

    No. Equillium is 4th by market cap among the 13 companies on this page; the largest is Immuneering (IMRX) at $240.27M.